# India Epilepsy Surgery Market

> India Epilepsy Surgery Market Research Report By Procedure Type (Respective Surgery, Laser Interstitial Thermal Therapy (LITT)) and By End User (Hospitals & Clinics, Specialty Centers) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.35%
- **2024:** $ 49.6 Million
- **2025:** $ 52.52 Million
- **2035:** $ 88 Million
- **Key Players:** Medtronic (IN), Johnson & Johnson (IN), Stryker (IN), Boston Scientific (IN), Abbott Laboratories (IN), NeuroPace (IN), LivaNova (IN), Nico Corporation (IN), Integra LifeSciences (IN)

**Report ID:** MRFR/HC/51355-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/india-epilepsy-surgery-market-53116

---

## Market Summary

## **India Epilepsy Surgery Market Overview**

As per MRFR analysis, the India Epilepsy Surgery Market Size was estimated at 73.12 (USD Million) in 2023. The India Epilepsy Surgery Market Industry is expected to grow from 78.5(USD Million) in 2024 to 147 (USD Million) by 2035. The India Epilepsy Surgery Market CAGR (growth rate) is expected to be around 5.869% during the forecast period (2025 - 2035)

**Key India Epilepsy Surgery Market Trends Highlighted**

The India Epilepsy Surgery Market is experiencing significant growth driven by a combination of factors. One of the key market drivers is the increasing incidence of epilepsy in the country, which affects both urban and rural populations. The government of India has been recognizing epilepsy as a health challenge, prompting a greater demand for surgical interventions as a treatment option. Advances in surgical techniques and technology, such as minimally invasive procedures, are also enhancing patient outcomes, making surgery a more viable option for many.

Moreover, rising healthcare expenditure and improved health infrastructure across the nation are facilitating access to quality epilepsy surgery services.

There are notable opportunities to be explored in the market as well. The growing awareness among the public about available treatments and the importance of timely intervention can lead to a higher rate of patients seeking surgical options. Collaboration between hospitals, epilepsy centers, and research institutions could also result in more innovative treatment possibilities, while further education and training of medical professionals will bolster the diagnosis and management of epilepsy in India. 

Recently, the trends reflect a shift towards personalized medicine, with a focus on tailoring surgical approaches to individual patient profiles.There has also been a rising emphasis on remote consultations and telemedicine solutions, particularly post-pandemic, which have improved access to specialists and informed decision-making for patients considering surgery. The focus on multidisciplinary teams in treating epilepsy is also gaining traction, ensuring that patients receive holistic care. 

Overall, the India Epilepsy Surgery Market is poised for growth, influenced by these dynamic trends and the commitment to improving healthcare outcomes for epilepsy patients across the nation.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**India Epilepsy Surgery Market Drivers**

**Increasing Prevalence of Epilepsy in India**

Epilepsy is a major public health concern in India, with an estimated incidence of 5-10 occurrences per 1,000 people. According to the Indian Epilepsy Association, around 12 million people in India suffer from this neurological illness. The growing awareness of epilepsy and its treatment, combined with increased research into viable surgical treatments, is propelling the India Epilepsy Surgery Market Industry. 

The Indian government and other health organizations have prioritized neurological illnesses, resulting in increased funding and policy measures. This focus on epilepsy emphasizes the necessity for invasive surgical therapies that are more successful than medicine for certain individuals, hence driving market growth.

**Advancements in Surgical Techniques and Technology**

Recent advancements in surgical techniques and technologies, such as minimally invasive procedures and intraoperative monitoring systems, have significantly enhanced the safety and efficacy of epilepsy surgeries. Organizations like the Indian Society of Epilepsy have been promoting new surgical methods, leading to better patient outcomes. 

Adoption of innovative technologies not only improves post-surgical recovery times but also ensures a higher success rate in seizure reduction, creating positive feedback loops encouraging more patients to opt for surgical interventions.These advancements represent a critical driver for the India Epilepsy Surgery Market Industry.

**Government Initiatives and Funding for Neurological Research**

The Government of India has recognized the need to address neurological disorders, including epilepsy, through various initiatives and increased funding allocation for Research and Development. The announcement of the National Mental Health Program aims to address mental health and neurological disorders systematically, including epilepsy surgeries. According to government reports, funding for neurology research increased by over 25% in the last five years, leading to improved training and resources for healthcare professionals.This government backing is driving innovations and subsequent surgical applications in the India Epilepsy Surgery Market Industry.

**Growing Awareness and Education on Epilepsy Treatment**

There has been a marked improvement in public awareness and education regarding epilepsy treatments, notably surgical options. Campaigns led by organizations such as the Epilepsy Foundation India have significantly improved the understanding of epilepsy among the general population, resulting in more patients recognizing their surgical options. Public outreach programs and seminars have increased patient inquiries about surgical interventions, resulting in a measurable rise in surgical consultations by approximately 30% in urban areas over the last few years.This growing awareness is fostering a more substantial engagement between patients and healthcare providers in the India Epilepsy Surgery Market Industry.

**India Epilepsy Surgery Market Segment Insights**

**Epilepsy Surgery Market Procedure Type Insights**

The Procedure Type segment of the India Epilepsy Surgery Market encompasses various surgical interventions designed to manage epilepsy conditions effectively, showcasing diverse methodologies that cater to patient needs. Among these, Respective Surgery stands out as a prominent approach, where specific resection of identified brain tissue is undertaken to alleviate seizures. This technique has garnered significant attention due to its relatively high success rates in seizure reduction and enhancement of quality of life for patients suffering from drug-resistant epilepsy. 

The intricate nature of Respective Surgery calls for advanced surgical techniques and technologies that are gaining traction in India, given the country's growing pool of qualified neurosurgeons and improved hospital infrastructure. Additionally, Laser Interstitial Thermal Therapy (LITT) is making significant inroads in this market. This minimally invasive procedure utilizes laser technology to target and destroy problematic brain tissue responsible for seizures. LITT presents numerous advantages over conventional techniques, including reduced recovery times, minimal invasiveness, and a lower risk of complications. 

With the Indian healthcare system's ongoing modernization and the increasing prevalence of epilepsy in the region, the shift towards innovative procedures such as LITT reflects a broader trend toward personalized medicine, tailored to individual patient conditions and needs. Furthermore, the rising awareness among the public and healthcare professionals regarding available treatment options continues to bolster investments in surgical therapies for epilepsy, contributing to the robust growth trajectory of this segment. 

Another driving factor is the growing number of epilepsy centers across India focused on providing comprehensive care, appreciating the distinctive roles that different procedures play in managing epilepsy disorders. In this evolving landscape, the Procedure Type segment will likely expand as technology advances, emphasizing the crucial role of effective surgical interventions in addressing the challenges posed by epilepsy. These elements combined paint a promising picture of the segment's potential impact on the overall trajectory of the India Epilepsy Surgery Market.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Epilepsy Surgery Market End User Insights**

The End User segment of the India Epilepsy Surgery Market is primarily categorized into Hospitals and Clinics, as well as Specialty Centers. Hospitals and Clinics play a crucial role in providing access to essential epilepsy surgical procedures and treatment options, addressing the needs of a large patient population across urban and rural regions of India. Specialty Centers are increasingly gaining importance, as they offer advanced diagnostic tools and tailored surgical protocols, thereby enhancing patient outcomes.

Given the rising prevalence of epilepsy in India, with estimates indicating millions affected, these facilities represent a significant aspect of the healthcare infrastructure.Moreover, ongoing investments in healthcare infrastructure and the integration of technological advancements in surgical techniques are expected to create ample opportunities for growth within this segment. As these healthcare facilities adapt to growing demands for epilepsy surgery, the End User segment will continue to experience transformation, ultimately enhancing the overall India Epilepsy Surgery Market. The evolving landscape, characterized by improved healthcare policies and rising awareness, further supports the growth potential in this sector.

**India Epilepsy Surgery Market Key Players and Competitive Insights**

The India Epilepsy Surgery Market is characterized by a rapidly evolving landscape driven by advancements in medical technology, an increasing awareness of epilepsy as a treatable condition, and a growing demand for specialized surgical interventions among patients suffering from drug-resistant epilepsy. The competitive insights into this market reveal a dynamic environment where healthcare providers are investing in state-of-the-art surgical techniques, skilled personnel, and patient-centric care models. Providers are forging partnerships with academic institutions and medical device manufacturers to enhance their service offerings and ensure they stay at the forefront of epilepsy surgical treatment. 

As the market expands, companies are also differentiating themselves through innovative research initiatives, effective marketing strategies, and outreach programs aimed at educating patients about the benefits of surgical options for epilepsy management.Manipal Hospitals has established a significant presence in the India Epilepsy Surgery Market, recognized for its multi-disciplinary approach that integrates neurology, neurosurgery, and rehabilitation. The institution boasts a robust network of healthcare facilities across India, allowing it to cater to a large demographic. Its strengths include a focus on advanced surgical techniques such as video EEG monitoring and responsive neurostimulation, which have proven effective in managing epilepsy. 

The hospital's commitment to high standards of patient care is evident in its highly skilled medical team and continuous investment in research and training programs, making it a preferred choice among patients seeking surgical interventions for epilepsy. Furthermore, its reputation for excellent patient outcomes enhances its competitive advantage within this specialized market.Max Healthcare also plays a crucial role in the India Epilepsy Surgery Market, offering comprehensive services that encompass diagnosis, surgical interventions, and postoperative care for epilepsy patients. The hospital group is known for its cutting-edge technologies, including minimally invasive surgical techniques that reduce recovery times and improve patient satisfaction. 

Max Healthcare's strategic partnerships with leading academic institutions have bolstered its research initiatives, enabling the development of innovative treatment modalities. The company actively engages in training and capacity-building programs for its staff, ensuring that best practices in epilepsy surgery are met. With a focus on continuous improvement, Max Healthcare remains committed to expanding its footprint in the Indian neurosurgery landscape, further intensified by potential mergers and acquisitions that can enhance its service capabilities and broaden its reach to those in need of epilepsy surgical care.

**Key Companies in the India Epilepsy Surgery Market Include**

**India Epilepsy Surgery Market Industry Developments**

The India Epilepsy Surgery Market has seen significant recent developments, with major hospitals expanding their capabilities and facilities to improve patient outcomes. Manipal Hospitals and Apollo Hospitals have introduced advanced surgical techniques, including laser interstitial thermal therapy, to enhance the precision of epilepsy surgeries. In September 2023, Max Healthcare opened a new neurology department dedicated to epilepsy care, further solidifying its role in the market. 

Furthermore, AIIMS is conducting cutting-edge research into neurostimulation techniques to treat epilepsy, showing the ongoing commitment to innovation in the field. Significant growth in market valuation has been reported, driven by the rising prevalence of epilepsy in India, which the Indian government indicates affects around 10 million people. 

In terms of mergers and acquisitions, no recent transactions involving major hospitals in this sector have been publicly reported. However, over the past few years, Fortis Healthcare has been enhancing its neurological services, and Sankara Nethralaya has been collaborating with research institutions to develop better treatment methods. Collectively, these trends reflect a proactive approach by leading healthcare providers in the country to address the challenges of epilepsy and expand surgical options available to patients.

**India Epilepsy Surgery Market Segmentation Insights**

**Epilepsy Surgery Market Procedure Type****Outlook**

**Epilepsy Surgery Market End User****Outlook**

## Market Drivers

### Rising Prevalence of Epilepsy

The increasing prevalence of epilepsy in India is a crucial driver for the India Epilepsy Surgery Market. According to the National Health Mission, approximately 10 million individuals in India are affected by epilepsy, with a significant portion experiencing drug-resistant epilepsy. This growing patient population necessitates the development of specialized surgical interventions, thereby propelling the demand for epilepsy surgeries. Furthermore, the rising incidence of neurological disorders, coupled with an aging population, is likely to contribute to the market's expansion. As healthcare providers seek effective treatment options for patients who do not respond to medication, the India Epilepsy Surgery Market is poised for growth, with an emphasis on innovative surgical techniques and comprehensive care.

### Government Initiatives and Policies

Government initiatives aimed at improving healthcare access and quality are pivotal for the India Epilepsy Surgery Market. The Indian government has implemented various programs to enhance neurological care, including the National Programme for Prevention and Control of Neurological Disorders. These initiatives focus on increasing awareness, providing training for healthcare professionals, and improving infrastructure for epilepsy treatment. Additionally, the introduction of health insurance schemes that cover surgical procedures for epilepsy is likely to encourage more patients to seek surgical options. As a result, the India Epilepsy Surgery Market is expected to benefit from these supportive policies, which aim to reduce the burden of epilepsy and improve patient outcomes.

### Rising Investment in Healthcare Infrastructure

Rising investment in healthcare infrastructure is a significant driver for the India Epilepsy Surgery Market. The Indian government and private sector are increasingly investing in the establishment of specialized epilepsy centers and advanced surgical facilities. This investment is aimed at improving access to quality healthcare services for epilepsy patients, particularly in rural and underserved areas. Enhanced infrastructure not only facilitates the delivery of surgical interventions but also supports research and development in epilepsy treatment. As more healthcare facilities are equipped with state-of-the-art technology and trained personnel, the India Epilepsy Surgery Market is likely to witness substantial growth, ultimately leading to better patient care and outcomes.

### Technological Advancements in Surgical Procedures

Technological advancements in surgical procedures are transforming the landscape of the India Epilepsy Surgery Market. Innovations such as minimally invasive techniques, robotic-assisted surgeries, and advanced imaging technologies are enhancing the precision and effectiveness of epilepsy surgeries. These advancements not only improve surgical outcomes but also reduce recovery times, making surgery a more appealing option for patients. The integration of neurostimulation devices and intraoperative monitoring further supports the trend towards more effective surgical interventions. As hospitals and surgical centers adopt these cutting-edge technologies, the India Epilepsy Surgery Market is likely to experience significant growth, driven by improved patient satisfaction and clinical success rates.

### Increased Collaboration Among Healthcare Providers

Increased collaboration among healthcare providers is emerging as a vital driver for the India Epilepsy Surgery Market. Multidisciplinary teams, including neurologists, neurosurgeons, and rehabilitation specialists, are working together to develop comprehensive treatment plans for epilepsy patients. This collaborative approach ensures that patients receive holistic care, addressing not only the surgical aspects but also the psychological and social dimensions of living with epilepsy. Furthermore, partnerships between hospitals and research institutions are fostering innovation in surgical techniques and patient management strategies. As these collaborative efforts continue to grow, the India Epilepsy Surgery Market is expected to benefit from enhanced treatment protocols and improved patient outcomes.

## Future Outlook

The India [Epilepsy Surgery Market](https://www.marketresearchfuture.com/reports/epilepsy-surgery-market-10676) is projected to grow at a 5.35% CAGR from 2025 to 2035, driven by advancements in surgical techniques, increasing awareness, and improved healthcare infrastructure.

**New opportunities:**

- Development of minimally invasive surgical techniques for epilepsy treatment.
- Expansion of telemedicine services for pre- and post-operative care.
- Partnerships with local hospitals for comprehensive epilepsy management programs.

By 2035, the market is expected to be robust, reflecting significant advancements and increased accessibility.

## Segment Insights

### By Surgery Type: Resective Surgery (Largest) vs. Functional Surgery (Fastest-Growing)

In the India Epilepsy Surgery Market, the market share distribution among the surgery types reveals that Resective Surgery holds the largest share, being the go-to option for many patients due to its effectiveness in managing epilepsy. This procedure, which involves the removal of the brain tissue responsible for seizures, is widely accepted and performed across various healthcare facilities. Meanwhile, Functional Surgery is emerging as a segment gaining momentum, appealing to patients and surgeons looking for innovative solutions that do not necessarily involve resection of brain tissues.

Resective Surgery (Dominant) vs. Functional Surgery (Emerging)

Resective Surgery, as the dominant approach in the India Epilepsy Surgery Market, focuses on excising the specific area of the brain where seizures originate, offering substantial relief for patients. This method is favored for its proven efficacy and established protocols, making it a preferred choice among neurosurgeons. On the other hand, Functional Surgery represents an emerging field that explores alternative techniques such as neuromodulation and cortical stimulation, which help manage seizure disorders with potentially fewer risks associated with traditional resections. As research advances, Functional Surgery is likely to gain traction as a viable option for patients with specific types of epilepsy, diversifying treatment choices and moving the market forward.

### By Indication: Drug-resistant Epilepsy (Largest) vs. Focal Epilepsy (Fastest-Growing)

In the India Epilepsy Surgery Market, the distribution of market share among the indications reveals that Drug-resistant Epilepsy stands out as the largest segment, accounting for a significant portion of surgical interventions. Following it, Focal Epilepsy exhibits promising growth, driven by increasing awareness and accessibility of targeted treatment options. Neurodegenerative Disorders and Generalized Epilepsy, while present, constitute smaller segments within this landscape, indicating a concentrated focus on drug-resistant patients for surgical intervention.

Drug-resistant Epilepsy (Dominant) vs. Focal Epilepsy (Emerging)

Drug-resistant Epilepsy is the dominant segment in the India Epilepsy Surgery Market due to the high prevalence of refractory cases that do not respond to medication. This segment is characterized by a stable demand for surgical procedures, which include techniques such as resective surgery and neuromodulation. Conversely, Focal Epilepsy is the emerging segment, gaining traction as more patients and healthcare providers recognize the efficacy of focused surgical interventions. The rise of minimally invasive techniques and increasing patient education are primary drivers behind its growth, positioning it as an attractive option for individuals with localized epileptogenic zones.

### By Patient Age Group: Adult (Largest) vs. Pediatric (Fastest-Growing)

In the India Epilepsy Surgery Market, the patient age group segment is predominantly represented by adults, reflecting a significant share of the market. The adult demographic encompasses individuals aged 18 years and older, who experience a higher prevalence of epilepsy due to various factors, including lifestyle, underlying health issues, and delayed diagnosis. On the other hand, the pediatric segment, which includes children up to 12 years of age, is gaining traction, supported by increasing awareness and advocacy for childhood epilepsy treatments.

Adult (Dominant) vs. Pediatric (Emerging)

The adult segment in the India Epilepsy Surgery Market is characterized by a more significant number of patients undergoing surgical interventions due to epilepsy, making it the dominant group. Many adults experience complex partial seizures and refractory epilepsy, necessitating surgery. In contrast, the pediatric segment is rapidly emerging as a vital component of the market due to rising rates of diagnosis and earlier intervention strategies. This age group benefits from advanced surgical techniques specially tailored for children, which are gaining recognition and support from healthcare practitioners. As awareness grows about pediatric epilepsy management, more families are seeking surgical options, positioning the pediatric segment as a fast-growing contributor to the overall market.

### By Surgical Technique: Open Surgery (Largest) vs. Minimally Invasive Surgery (Fastest-Growing)

In the India Epilepsy Surgery Market, Open Surgery holds a significant market share, making it the largest segment in terms of prevalent surgical techniques. This method has been widely adopted due to its effectiveness in treating various forms of epilepsy, particularly in patients with complex cases. On the other hand, Minimally Invasive Surgery is emerging rapidly, capturing the attention of both patients and surgeons alike with its reduced recovery times and lower complication rates. This growing preference reflects an overall trend towards less invasive options in surgical treatments.

Surgical Procedures: Open Surgery (Dominant) vs. Minimally Invasive Surgery (Emerging)

Open Surgery remains the dominant technique in the India Epilepsy Surgery Market due to its reliability and effectiveness, especially for patients with severe epilepsy resistant to medication. Surgeons have extensive experience with this method, leading to well-established best practices and patient outcomes. Meanwhile, Minimally Invasive Surgery is emerging as a preferred option, particularly among younger patients who prioritize quicker recovery and minimal scarring. The technique utilizes advanced imaging and technology to reduce risk, making it attractive for urban centers. As awareness and training for these newer techniques increase, more healthcare providers are likely to adopt minimally invasive methods, further shaping the market dynamics.

### By Postoperative Care: Inpatient Care (Largest) vs. Outpatient Care (Fastest-Growing)

In the India Epilepsy Surgery Market, the postoperative care segment is predominantly comprised of Inpatient Care, which commands the largest share due to its intensive and comprehensive nature. It encompasses extended hospital stays, where patients receive close monitoring and immediate interventions post-surgery. Following closely, Outpatient Care has emerged as a fast-growing segment, driven by the increasing number of epilepsy surgeries performed and the subsequent need for efficient postoperative management in an outpatient setting. 

The growth trends in this segment are significantly influenced by factors such as the rising prevalence of epilepsy, advancements in surgical techniques, and a shift toward more cost-effective outpatient care models. Additionally, the increasing awareness and acceptance of epilepsy surgery among patients have further propelled the demand for follow-up care services, indicating an evolution in patient management strategies to enhance recovery and prevent complications.

Inpatient Care (Dominant) vs. Rehabilitation Services (Emerging)

Inpatient Care stands as the dominant value within the postoperative care segment as it provides critical support during the initial recovery phase after epilepsy surgery. This segment ensures comprehensive monitoring and management of patient health, addressing complications, and providing immediate therapeutic interventions. On the other hand, Rehabilitation Services represent an emerging value, focusing on the long-term recovery and quality of life improvement for postoperative patients. This service segment is gaining traction as more patients and healthcare providers recognize the importance of tailored rehabilitation programs. These programs may include physical therapy, cognitive rehabilitation, and psychosocial support, aimed at helping patients reintegrate into daily life and manage any residual effects of surgery.

## Competitive Benchmarking

The Epilepsy Surgery Market in India is characterized by a dynamic competitive landscape, driven by increasing prevalence of epilepsy and advancements in surgical techniques. Key players such as Medtronic (IN), Johnson & Johnson (IN), and Stryker (IN) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (IN) focuses on innovation, particularly in developing advanced neurostimulation devices, while Johnson & Johnson (IN) emphasizes strategic partnerships to expand its product offerings. Stryker (IN) is actively pursuing mergers and acquisitions to bolster its technological capabilities, thereby shaping a competitive environment that is increasingly reliant on cutting-edge solutions and collaborative efforts.

The business tactics employed by these companies include localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in a market like India. The competitive structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they drive technological advancements and set industry standards that smaller firms often follow.

In December 2025, Medtronic (IN) announced the launch of a new line of minimally invasive surgical tools designed specifically for epilepsy procedures. This strategic move is likely to enhance their product portfolio and cater to the growing demand for less invasive surgical options, potentially increasing their market share in the region. The introduction of these tools may also signify a shift towards more patient-centric approaches in surgical interventions.

In November 2025, Johnson & Johnson (IN) entered into a partnership with a leading Indian research institution to develop innovative surgical techniques for epilepsy treatment. This collaboration is expected to leverage local expertise and accelerate the development of tailored solutions, thereby enhancing their competitive edge in the Indian market. Such partnerships may also facilitate quicker regulatory approvals and market entry for new products.

In October 2025, Stryker (IN) completed the acquisition of a local medical device company specializing in neurotechnology. This acquisition is anticipated to strengthen Stryker's position in the epilepsy surgery segment by integrating advanced technologies and expanding their product offerings. The strategic importance of this move lies in Stryker's ability to enhance its technological capabilities and respond more effectively to the evolving needs of healthcare providers in India.

As of January 2026, current competitive trends in the Epilepsy Surgery Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in surgical procedures. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, innovative solutions, and reliable supply chains. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge in the market.

## Recent News & Developments

The India Epilepsy Surgery Market has seen significant recent developments, with major hospitals expanding their capabilities and facilities to improve patient outcomes. Manipal Hospitals and Apollo Hospitals have introduced advanced surgical techniques, including laser interstitial thermal therapy, to enhance the precision of epilepsy surgeries. In September 2023, Max Healthcare opened a new neurology department dedicated to epilepsy care, further solidifying its role in the market. 

Furthermore, AIIMS is conducting cutting-edge research into neurostimulation techniques to treat epilepsy, showing the ongoing commitment to innovation in the field. Significant growth in market valuation has been reported, driven by the rising prevalence of epilepsy in India, which the Indian government indicates affects around 10 million people. 

In terms of mergers and acquisitions, no recent transactions involving major hospitals in this sector have been publicly reported. However, over the past few years, Fortis Healthcare has been enhancing its neurological services, and Sankara Nethralaya has been collaborating with research institutions to develop better treatment methods. Collectively, these trends reflect a proactive approach by leading healthcare providers in the country to address the challenges of epilepsy and expand surgical options available to patients.

## Report Scope

| MARKET SIZE 2024 | 49.6(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 52.52(USD Million) |
| MARKET SIZE 2035 | 88.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.35% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (IN), Johnson & Johnson (IN), Stryker (IN), Boston Scientific (IN), Abbott Laboratories (IN), NeuroPace (IN), LivaNova (IN), Nico Corporation (IN), Integra LifeSciences (IN) |
| Segments Covered | Surgery Type, Indication, Patient Age Group, Surgical Technique, Postoperative Care |
| Key Market Opportunities | Adoption of advanced surgical techniques and technologies enhances treatment options in the India Epilepsy Surgery Market. |
| Key Market Dynamics | Rising demand for advanced surgical techniques drives innovation in India's epilepsy surgery market. |
| Countries Covered | India |

## Frequently Asked Questions

**Q: What is the current valuation of the India Epilepsy Surgery Market?**
A: The market valuation was 49.6 USD Million in 2024.

**Q: What is the projected market size for the India Epilepsy Surgery Market by 2035?**
A: The projected valuation for 2035 is 88.0 USD Million.

**Q: What is the expected CAGR for the India Epilepsy Surgery Market during the forecast period?**
A: The expected CAGR for the market from 2025 to 2035 is 5.35%.

**Q: Which companies are the key players in the India Epilepsy Surgery Market?**
A: Key players include Medtronic, Johnson & Johnson, Stryker, and Boston Scientific.

**Q: What are the primary segments of the India Epilepsy Surgery Market by surgery type?**
A: Segments include Resective Surgery, Functional Surgery, Lesionectomy, and Hemispherectomy.

**Q: How does the market perform in terms of drug-resistant epilepsy?**
A: The segment for drug-resistant epilepsy was valued between 20.0 and 35.0 USD Million.

**Q: What is the market valuation for pediatric patients in the India Epilepsy Surgery Market?**
A: The pediatric segment was valued between 9.9 and 17.5 USD Million.

**Q: What surgical techniques are utilized in the India Epilepsy Surgery Market?**
A: Surgical techniques include Open Surgery, Minimally Invasive Surgery, Laser Ablation, and Stereotactic Surgery.

**Q: What is the valuation range for outpatient care in the postoperative care segment?**
A: Outpatient care was valued between 10.0 and 18.0 USD Million.

**Q: How does the market address different patient age groups?**
A: The market segments include Pediatric, Adolescent, Adult, and Geriatric age groups, with adult care valued between 24.0 and 42.0 USD Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-epilepsy-surgery-market-53116*